Skip to main content

Advertisement

Table 1 Clinical characteristics and the proportion of SEMG+ and SEMG− in subjects

From: Relationship between Semenogelins bound to human sperm and other semen parameters and pregnancy outcomes

Characteristics Patients (N = 142) Control (N = 13)
Mean ± SD Median Min-max Mean ± SD Median Min-max
Age (years) 36.5 ± 6.6 35.5 21–60 30.1 ± 4.1 29.5 25–36
Vol (mL) 4.25 ± 1.73 3.75 1.2–9.3 N/A N/A N/A
Conc (×106/mL) 50.6 ± 58.0 33.9 0.0004–400 76.8 ± 7.3 81.5 45.9–167.8
Mot (%) 27.5 ± 19.9 25.75 0–86.1 63.4 ± 2.1 61.05 50.8–86.6
TSC (×106/mL) 208.7 ± 19.8 143.5 0.003–1475 N/A N/A N/A
Viability (%) 55.76 ± 19.3 58.7 1.8–87.6 N/A N/A N/A
SEMG+ (%) 71.2 ± 20.2 73.5 12.2–99.2 20.0 ± 11.8 18.6 6.1–53.2
SEMG− (%) 28.8 ± 20.2 26.5 0.8–87.8 80.0 ± 11.8 81.4 46.8–93.9
  1. SEMG+ SEMG-positive spermatozoa, SEMG− SEMG-negative spermatozoa; Patients: male infertile patients; Control: normal healthy male subjects with pregnant wives
  2. Mean values of each parameter for patients and control subjects were compared using Wilcoxon rank sum test, which revealed significant differences concerning all parameters compared
  3. Vol (semen volume)
  4. N/A (not applicable)
  5. Conc (sperm concentration)
  6. Mot (total sperm motility)
  7. TSC (total sperm count)
  8. Viability (sperm viability)